1 completed, 1 suspended. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Suspended 1 |
| Phase 1 | 1 | Suspended 1 |
Follow Open Heart Surgery: new trials by email Literature Review of Open Heart Surgery trials Research Report on Open Heart Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Propranolol Treatment for Postoperative Chylothorax Propranolol Hydrochloride, Placebo - Postoperative Chylothorax, Congenital Heart Disease | Phase 1 / Phase 2 | Suspended | June Wu | 50 | 2025-09-09 | 2026-05-15 |
| Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery Ilofotase alfa, Placebo - Open Heart Surgery | Phase 2 | Completed | AM-Pharma | 271 | 2023-12-19 | 2026-09-29 |
Chylothorax (1) · Heart Defects, Congenital (1)
Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Heart Diseases (1) · Pleural Diseases (1) · Respiratory Tract Diseases (1)
2-Propanol (1) · Propranolol (1)
Belgium (1) · Germany (1) · Netherlands (1) · Switzerland (1) · United Kingdom (1) · United States (1)
June Wu, MD (1)